Navigation Links
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
Date:11/15/2012

x Technologies/St. Maris Pharma
G.Ex Technologies/St. Maris Pharma is a consortium of management consultant, general pharmaceutical, clinical pharmacy and marketing executives, each with over twenty-five years of industry experience and well versed in the changing dynamics of the prescription and OTC drug international marketplace. Actively supported by medical practice professionals in business and academia who have been involved in the management of related drug therapies for many years, the consortium is poised to champion the successful introduction of IRT-103 LDN and IRT-104 LDN in the territory.  

About TNI BioTech, Inc.
TNI BioTech, Inc., is a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using our patented immunotherapy. Our products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.

Our proprietary technology, therapies and patents, will be used to treat a wide range of cancers. Our most advanced clinical programs involve immunotherapy that works by isolating a patient's lymphocytes and then incubating them together with Methionine Enkephalin (MENK) in an enriching external incubation system. After incubation the patient's lymphocytes are re-infused back into the patient where they combat and destroy tumor cells.

Even though Management considers any condition that results in altered-immune response a target for investigation, the Company will most likely pursue additional investigations for MENK as a valuable candidate in the treatment of the following:

  • Autoimmune states such as rheumatoid arthritis and multiple sclerosis;
  • As an adjunct to antibiotics in the treatment of infectious diseases;
  • In cancer patients undergoing chemotherapy, radiation tr
    '/>"/>

SOURCE TNI BioTech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
2. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
3. RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
4. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
5. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
6. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
7. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
8. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
9. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
10. Bacterin International Signs Its Third National GPO Contract with Novation
11. MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013   Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...
(Date:6/17/2013)... , June 17, 2013 DNAtrix Inc., experts ... will present clinical data on the company,s lead product, ... Quebec City, Canada on June ... DNAtrix,s CEO and a leader in the field of ... study entitled A PHASE I TRIAL OF A CONDITIONALLY ...
(Date:6/17/2013)... The following is a Statement of Steve Pasierb , ... Last Friday, Urban Outfitters issued a ... prescription drug paraphernalia products. The statement read, "In this extensive ... there may be individual items that are misinterpreted by people ... misinterpretation we are electing to discontinue these few styles from ...
Breaking Medicine Technology:Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2A Win for Families: Urban Outfitters Halts Prescription Drug Paraphernalia Product Sales 2
(Date:6/18/2013)... (PRWEB) June 18, 2013 Sun Buick GMC, ... Family Health Services 20th Annual Golf Tournament on Thursday, June ... The hole-in-one prize is a 2013 Buick Verano and will ... gets a hole-in-one on Irem’s 7th hole. , The MFHS ... format is a four person captain and crew team for ...
(Date:6/18/2013)... have a much different and more complex ... of Texas at Dallas have found that exploiting these ... cancer. , In an article published online May 21 ... researchers compared the metabolic characteristics of non-small-cell lung cancer ... patient. , They found that the cancer cells ...
(Date:6/18/2013)... discovered and mapped the signaling network between two previously ... cut off cancer cell growth at its starting point. ... of Texas MD Anderson Cancer Center reported the tie ... drug target, and MCM7, a protein vital to the ... of Cancer Cell . , "MCM7 overexpression marks ...
(Date:6/18/2013)... 2013 The Elizabeth Glaser Pediatric AIDS ... the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) ... new milestones in the global effort to eliminate pediatric ... that as of June 2013, one million babies globally ... Since PEPFAR’s inception in 2003, EGPAF has been a ...
(Date:6/18/2013)... Healthcare Solutions , the parent ... today announced the appointment of Richard Leonardo to ... position, Leonardo will direct Healthcare Solutions’ national sales ... initiatives. , Recognized in the property and casualty ... more than 20 years of experience in business ...
Breaking Medicine News(10 mins):Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2
... sexual adaptation shows that evidence is building for what ... appearing in Current Directions in Psychological Science, physical and ... males have evolved to deliver their sperm more effectively ... people are familiar with the idea of animals competing ...
... spider, a cousin to the well-known black widow, is increasingly ... is belongs to a group that is officially known as ... as "fiddleback" spiders or "violin" spiders because of the violin-shaped ... and thorax). ,The spiders are generally found in ...
... Union Minister of State for Environment and Forests, Shri ... century just as information technology dominated the last century. ... Consultative Committee of the Ministry of Environment and Forests, ... on Genetic Engineering Approval Committee has been vacated today ...
... In line with Ranbaxy Laboratories aggressive international expansion ... has solidified the acquisition of Be-Tabs Pharmaceuticals ... ,The deal is valued at R500 million ... fifth largest generic pharmaceutical company in South Africa. ...
... the champagne bottles which contained the weed killer that poisoned ... to him by a person well known to him-bowling coach Mustaq ... the team manager Talat Ali was witness to this. ... and Talat Ali knew the person or persons who handed over ...
... Concern over side effects of various drugs could be ... profile recalls like Vioxx, the osteoarthritis drug. ... Boston researchers at the Tufts-New England Medical Center. ... of Health Affairs, researchers compared half a dozen risky ...
Cached Medicine News:Health News:Louisiana Residents Warned Against Brown Recluse Spiders 2Health News:Biotechnology Will Dominate The 21st Century 2Health News:Ranbaxy Labs Extends Roots in South Africa 2Health News:Ranbaxy Labs Extends Roots in South Africa 3Health News:Drug Risks Must Be Balanced Against Benefits, Researchers 2
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity....
... Mitral bioprosthesis is a portrait ... based on 25 years of ... makes it an excellent choice ... replacement--particularly elderly patients and those ...
... Implantable defibrillators are used to treat ... life threatening. Implantable cardioverter defibrillators (ICDs) often ... (SCD), and have been found to reduce ... from as high as 55 percent to ...
Medicine Products: